loadpatents
name:-0.042055130004883
name:-0.010648012161255
name:-0.011050939559937
Wall; G. Michael Patent Filings

Wall; G. Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wall; G. Michael.The latest application filed is for "treatment of ferroptosis".

Company Profile
9.10.32
  • Wall; G. Michael - Fort Worth TX
  • Wall, G. Michael - Forth Worth TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatment Of Ferroptosis
App 20220304955 - Wall; G. Michael ;   et al.
2022-09-29
N-Acetylcysteine Amide (NACA) and (2R,2R')-3,3' disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) for the Prevention and Treatment of Radiation Dermatitis and Skin Lightening, Skin Whitening and Skin Improvement
App 20220105056 - Wall; G. Michael
2022-04-07
N-Acetylcysteine Amide (NACA) and (2R,2R')-3,3' disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) for the Prevention and Treatment of Radiation Pneumonitis and Treatment of Pulmonary Function in Cystic Fibrosis
App 20220062203 - Wall; G. Michael
2022-03-03
Method for Preparation of N-Acetyl Cysteine Amide and Derivatives Thereof
App 20220024866 - Wall; G. Michael ;   et al.
2022-01-27
Treatment Of Cystinosis
App 20210378993 - Wall; G. Michael ;   et al.
2021-12-09
Method for preparation of N-acetyl cysteine amide and derivatives thereof
Grant 11,091,433 - Wall , et al. August 17, 2
2021-08-17
Prodrug For The Treatment Of Disease And Injury Of Oxidative Stress
App 20210228509 - Wall; G. Michael
2021-07-29
Methods of Making Deuterium-Enriched N-acetylcysteine Amide (D-NACA) and (2R, 2R')-3,3'-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress
App 20200385342 - Wall; G. Michael
2020-12-10
Method for Preparation of N-Acetyl Cysteine Amide and Derivatives Thereof
App 20200277258 - Wall; G. Michael ;   et al.
2020-09-03
Treatment of Age-Related Macular Degeneration, Glaucoma, and Diabetic Retinopathy with N-Acetylcysteine Amide (NACA) or (2R,2R')
App 20200222344 - Wall; G. Michael
2020-07-16
Quantitation of Free and Total N-Acetylcysteine Amide and Its Metabolite N-Acetylcysteine in Human Plasma Using Derivatization a
App 20200217852 - Wall; G. Michael ;   et al.
2020-07-09
Method for preparation of N-acetyl cysteine amide and derivatives thereof
Grant 10,590,073 - Wall , et al.
2020-03-17
Compositions And Methods For Treatment Of Eye Diseases
App 20190151271 - Campochiaro; Peter A. ;   et al.
2019-05-23
Methods of Making Deuterium-Enriched N-acetylcysteine Amide (D-NACA) and (2R, 2R')-3,3'-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress
App 20190135741 - Wall; G. Michael
2019-05-09
Method for Preparation of N-Acetyl Cysteine Amide and Derivatives Thereof
App 20190084926 - Wall; G. Michael ;   et al.
2019-03-21
Method Of Delivering Nasal Spray
App 20170172974 - Cagle; Gerald D. ;   et al.
2017-06-22
Method Of Treating Middle Ear Infections
App 20160361324 - Wall; G. Michael ;   et al.
2016-12-15
Method Of Treating Middle Ear Infections
App 20160243029 - Wall; G. Michael ;   et al.
2016-08-25
Method of treating middle ear infections
Grant 9,402,805 - Wall , et al. August 2, 2
2016-08-02
Method of treating middle ear infections
Grant 9,345,714 - Wall , et al. May 24, 2
2016-05-24
Method Of Treating Middle Ear Infections
App 20150374716 - Wall; G. Michael ;   et al.
2015-12-31
Method of treating middle ear infections
Grant 9,149,486 - Wall , et al. October 6, 2
2015-10-06
Method Of Treating Middle Ear Infections
App 20140363511 - Wall; G. Michael ;   et al.
2014-12-11
Method of treating middle ear infections
Grant 8,846,650 - Wall , et al. September 30, 2
2014-09-30
Method Of Delivering Nasal Spray
App 20140227326 - Cagle; Gerald D. ;   et al.
2014-08-14
Olopatadine Nasal Spray Regimen For Children
App 20140007865 - Wall; G. Michael
2014-01-09
Olopatadine formulations for topical nasal administration
Grant 8,399,508 - Singh , et al. March 19, 2
2013-03-19
Methods And Compositions For Applying Moxifloxacin To The Ear
App 20120289541 - Sawchuk; Ronald J. ;   et al.
2012-11-15
Olopatadine Formulations For Topical Nasal Administration
App 20110306659 - Singh; Onkar N. ;   et al.
2011-12-15
Olopatadine formulations for topical nasal administration
Grant 7,977,376 - Singh , et al. July 12, 2
2011-07-12
Olopatadine Nasal Spray Regimen For Children
App 20110011392 - Wall; G. Michael
2011-01-20
Method Of Treating Middle Ear Infections
App 20090156566 - Wall; G. Michael ;   et al.
2009-06-18
Method Of Treating Middle Ear Infections
App 20080214513 - Wall; G. Michael ;   et al.
2008-09-04
Olopatadine formulations for topical nasal administration
App 20070142458 - Singh; Onkar N. ;   et al.
2007-06-21
Method of delivering nasal spray
App 20060110328 - Cagle; Gerald D. ;   et al.
2006-05-25
Method of treating middle ear infections
App 20050059674 - Wall, G. Michael ;   et al.
2005-03-17
Compositions for removing human cerumen
App 20040126436 - Cagle, Gerald D. ;   et al.
2004-07-01
Use of an anti-allergy agent and a steroid to treat nasal conditions
App 20040097474 - Cagle, Gerald D. ;   et al.
2004-05-20
Antifungal compositions containing an antibiotic and one or more amidoamines
App 20040033208 - Cagle, Gerald D. ;   et al.
2004-02-19
Method of treating middle ear infections
App 20030139382 - Wall, G. Michael ;   et al.
2003-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed